13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 88 holding rows worth $2,461,043,000.
- Accession
- 0001583977-21-000009
- Filer
- CIK 1583977
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 88 entries on the cover page, a total value of $2,461,043,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,461,043,000 with VALUE read as thousands by filing date, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ERASCA INC COM | 29479A108 | Stock | 10,505,550 | $216,845,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 2,842,297 | $188,814,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 4,928,756 | $172,802,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 4,720,495 | $109,468,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,144,700 | $86,511,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,073,485 | $84,705,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,768,909 | $82,909,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 5,364,850 | $78,810,000 | thousands by filing date | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,012,079 | $74,752,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 3,102,199 | $67,957,000 | thousands by filing date | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 2,252,626 | $58,451,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,370,914 | $55,957,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 1,815,546 | $53,450,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 2,162,115 | $53,253,000 | thousands by filing date | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 3,899,185 | $48,814,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 1,848,024 | $43,817,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 2,030,691 | $41,962,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 3,170,872 | $37,955,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,000,000 | $35,740,000 | thousands by filing date | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 2,326,660 | $34,807,000 | thousands by filing date | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 2,486,386 | $33,097,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 709,224 | $32,667,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,278,276 | $32,519,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,444,831 | $31,136,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 925,000 | $30,488,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 968,550 | $28,950,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,727,273 | $28,724,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 950,000 | $27,588,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 170,000 | $27,096,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,500,000 | $27,000,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 4,807,557 | $25,240,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 350,000 | $23,016,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 120,000 | $21,229,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 322,240 | $20,975,000 | thousands by filing date | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 2,273,221 | $20,155,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,611,623 | $19,597,000 | thousands by filing date | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 1,024,161 | $18,937,000 | thousands by filing date | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 1,069,932 | $18,154,000 | thousands by filing date | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 2,226,128 | $17,197,000 | thousands by filing date | |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 1,215,847 | $16,349,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 150,000 | $15,422,000 | thousands by filing date | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 1,983,165 | $15,140,000 | thousands by filing date | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 200,000 | $14,498,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 500,000 | $14,270,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 600,000 | $13,410,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 608,123 | $13,147,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 950,000 | $13,100,000 | thousands by filing date | |
| ICOSAVAX INC | 45114M109 | COM | 426,393 | $12,238,000 | thousands by filing date | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 689,731 | $12,229,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 500,000 | $11,950,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 48,132 | $11,209,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 385,081 | $10,443,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 667,167 | $10,348,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 100,000 | $10,061,000 | thousands by filing date | |
| DERMTECH INC | 24984K105 | COM | 300,000 | $9,633,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 100,000 | $8,701,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 350,000 | $8,488,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 482,413 | $8,143,000 | thousands by filing date | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 1,305,095 | $8,065,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 288,330 | $7,785,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 239,548 | $7,668,000 | thousands by filing date | |
| Veru Inc | 92536C103 | Common Stock | 800,000 | $6,824,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 300,000 | $6,732,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 3,000,000 | $6,540,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 100,000 | $5,664,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 342,562 | $5,635,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 250,000 | $5,500,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 144,439 | $4,908,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 552,903 | $4,888,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 394,500 | $4,580,000 | thousands by filing date | |
| RENOVACOR INC | 75989E106 | COM | 500,000 | $4,525,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 430,000 | $4,275,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 540,600 | $4,271,000 | thousands by filing date | |
| GALECTO INC | 36322Q107 | COM | 1,150,730 | $4,131,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 479,506 | $4,081,000 | thousands by filing date | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 346,524 | $3,999,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 478,200 | $3,481,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 203,153 | $3,263,000 | thousands by filing date | |
| SORRENTO THERAPEUTICS INC | 83587F202 | COMMON STOCK | 400,000 | $3,052,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 392,167 | $2,569,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 198,382 | $2,494,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 1,000,000 | $2,340,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 273,500 | $1,704,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 256,649 | $590,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 103,980 | $550,000 | thousands by filing date | |
| IMV INC | 44974L103 | COM | 234,374 | $385,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 95,744 | $167,000 | thousands by filing date | |
| OUTLOOK THERAPEUTICS INC | 69012T115 | *W EXP 02/18/202 | 270,698 | $54,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001583977-21-000009 | this filing | 2021-11-15 | acceptance time not in the bulk data set |